|
Description:
|
|
The U.S. Preventive Services Task Force recently finalized their recommendation that men ages 55 to 69 should speak with their health care providers about prostate cancer screening using the prostate-specific antigen, or PSA. We’ll discuss the latest on the procedure, which has a significant problem with false positives. We discuss the latest on the procedure, which has a significant problem with false positives, and hear about developments in research on prostate cancer.
Guests:
Dr. Paul Alpert, clinical professor, department of urology, UCSF Medical Center
Dr. Mark S. Litwin, professor of urology and public health and urology department chair, UCLA
Related Links:
New Evidence for the Benefit of Prostate-specific Antigen Screening: Data From 400,887 Kaiser Permanente Patients (Urology Journal)
 |
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation
